Viewing Study NCT06875193

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:15 AM
Ignite Modification Date: 2026-05-09 @ 12:52 AM
Study NCT ID: NCT06875193
Status: RECRUITING
Last Update Posted: 2025-03-17
First Post: 2025-02-24
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: DM Treatment to Evaluate the Efficacy and Safety of Dapagliflozin or Pioglitazone in Patients with Type 2 Diabetes
Sponsor: Dong Wha Pharmaceutical Co. Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type2diabetes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Dapagliflozin View
None Pioglitazone View
None DPP-4 inhibitor View